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The European urology guidelines have been written since
1996. In 2000, experts included sections on ejaculation dis-
ordersanderectiledysfunction.1Since then,eachyear, theyare
updated with the competition of specialists from different
continents. In 2014, authors introduced the term priapism,2
and they maintained it until 2018. That same year the guide-
lines were modified based on the new online educational
courses designed by the EAU expert panels and a group of
young urologists. For the year 2020 and with the consultation
of more than 250 experts from 72 countries, the guidelines
gathered in a single chapter (Sexual and Reproductive Health)
with extensive content that is worth consulting.
Among the novelties, there is a complete change in the
chapter regarding the hypogonadism. The use of testoster-
one replacement is recommended in patients with abnormal
values andwith erectile dysfunction supported by the Sexual
Function trial of testosterone trials since experts previously
recommended first use of PDE5 inhibitors. Another issue is
the explanation of the effects of hormonal replacement on
organs such as prostate and breast as well as how this affects
the cardiovascular system.
The treatment approach for managing erectile dysfunction
changed. After an initial evaluation with a detailed medical
history, authors suggest identifying the expectations of the
patients to make a joint decision and also offer treatment of
physical and psychosexual aspects. Psychosexual therapy con-
tinues tobeanessential tool in the treatment, better if there is a
good follow-up. In the case of choosing a behavioral and
cognitive therapy (CBT), they suggest considering its combina-
tion with pharmacotherapy. Subsequently, there are different
treatment alternatives such as intracavernous injections, vacu-
um devices, oral therapy with a PDE5 inhibitor and topical and
intraurethral treatments. All considered as first line of treat-
ments. Shock wave intervention3 is also recommended as an
option in vasculogenic patients with prior informed consent
and after previous treatments as the first line of treatment.
The management of Peyronie’s disease was extensively
reviewed, considering the publication of many of the genes
involved in its pathophysiology and its relationship with
Dupuytren’s disease.4 Only oral non-steroidal anti-inflamma-
tory drugs (NSAIDs) and phosphodiesterase inhibitors are
considered as oral therapy and other options previously con-
sidered withdrawn. Despite the recent withdrawal from the
Europeanmarket of collagenase of clostridiumhistolyticumby
its marketing company, the results of the most significant
studies regarding the improvement of penile curvature based
on the IMPRESS study (Investigation for Maximal Peyronie’s
reduction efficacy and safety studies) were published.5 The
curvature improvement is 34% versus 18.2% in the placebo
group. Patients with curvatures between 30 and 60degrees,
IIEF greater than 17, without calcified plaques and a longer
duration of the disease, were those who benefited the most
from the treatment. A new shorter protocol for administration
of collagenase was mentioned.6 The use of interferon-a-2b is
included as a recommended treatment in the stable phase of
the disease due to a 20% reduction in curvature in a recent
study, and the few side effects it can cause. Experts reviewed
other types of treatments, such as traction therapy. Although
they mentioned them as a possible safe and effective option,
current studies do not support their use as monotherapy. The
vacuumdevices are alsomentionedasapossiblemechanismof
mechanical straightening of the curvature but with only one
study that recommends it as monotherapy.
Regarding surgical management, they better described the
surgical technique of penile shortening techniques, reporting
penile rectification rates greater than 85%. They mentioned
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techniques with geometric principles as an option and tunic
shortening and lengthening procedures, taking into account
the latter types of grafts used and the results obtained.
In the chapter on ejaculation disorders, they completely
described the pathophysiology and possible causes of hema-
tospermia. In addition to mentioning the types of studies that
must be performed, they also reported how to investigate the
cause in the initial presentation and recurrent cases.
In male infertility, experts presented a text with many
modifications (the first published in 2001, updated several
years and in 2017 expanded to cover areas not previously
mentioned). The diagnostic algorithm emphasizes the eval-
uation with the fragmentation index (DFI).
There is a critical correlation of intrauterine insemination
and in vitro fertilization (IVF) with the success rate of preg-
nancy. There is a new complete explanation about assisted
reproduction techniques and some of its characteristics. The
guidelines emphasize the role of ultrasound in evaluation,
mainly for measuring testicular volume, determining abnor-
malities in the structureof the testicle (testiculardysgenesis or
tumors), and seeing possible indirect signs of obstruction. In
infertility-related conditions, the possible role of varicocelec-
tomy in patients with non-obstructive azoospermia, hypogo-
nadism, or patients with altered DNA fragmentation is
mentioned as a possible alternative.
There are also invasive treatment options (they refer to
the types of sperm retrieval technique and their success rates
and surgical techniques for reconstruction of the seminal
tract depending on the site of obstruction or compromise).
Besides, there are non-invasive techniques (such as changes
in lifestyle, hormonal therapy and antioxidants).
Finally, these guidelines, for the first time, reviewed the
effects of urological conditions on sexual and reproductive
health. There are interesting relationships of varicocele with
cardiovascular disease, the psychological effects of prostate
cancer on sexual function and the well-known relationship
of erectile dysfunction and cardiac conditions. Priapism,
male contraception, or vasectomy chapters have no other
updates.
In conclusion, the European Guidelines of Urology 2020
are mandatory reading for beginners and experts on the
subject. There are novel findings that must be consulted by
urologists and residents from all over the world.
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